Washington Trust Advisors, Inc. Guardant Health, Inc. Transaction History

Washington Trust Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$20.94 - $38.01 $2,743 - $4,979	-131 Reduced 42.39%	178 $6,000
Q4 2022 Feb 08, 2023	SELL	$25.44 - $59.78 $21,852 - $51,351	-859 Reduced 73.54%	309 $8,000
Q3 2022 Oct 14, 2022	BUY	$43.66 - $61.0 $2,444 - $3,416	56 Added 5.04%	1,168 $63,000
Q2 2022 Jul 25, 2022	BUY	$28.82 - $77.35 $951 - $2,552	33 Added 3.06%	1,112 $45,000
Q1 2022 May 05, 2022	SELL	$48.25 - $100.49 $6,031 - $12,561	-125 Reduced 10.38%	1,079 $71,000
Q4 2021 Feb 11, 2022	BUY	$88.71 - $120.43 $106,806 - $144,997	1,204 New	1,204 $120,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Washington Trust Advisors, Inc. with notifications on news.